Newswire
ภาษาไทย
English-
CISION PR Newswire - BCI Shines at the RE+2025 Energy Expo in Las Vega...
LAS VEGAS, Sept. 15, 2025 /PRNewswire/ -- BCI, an Indonesian solar cell manufacturer, achieved remarkable success at the 2025 RE+ Expo held in Las Vegas from September 8-11. As North America's... -
CISION PR Newswire - StarHub Launches First-of-Its Kind 'Dynamic Ad Pod...
Singapore's first solution that replaces ads in live broadcast TV channels with personalised messages, targeted screen by screen SINGAPORE, Sept. 15, 2025 /PRNewswire/ -- StarHub is reshaping T... -
CISION PR Newswire - WePlay Teams Up with CHIBI MARUKO-CHAN to Celebrat...
TOKYO, Sept. 15, 2025 /PRNewswire/ -- The highly popular social entertainment app WePlay announced today that, to express gratitude for users' longstanding support, it has invited the iconic Japanese ... -
CISION PR Newswire - MGI Tech Introduces DNBSEQ-T7+: A Next-Generation ...
SHENZHEN, China, Sept. 15, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, announced the lau... -
CISION PR Newswire - Home Control (1747.HK) Announces Strategic Expansi...
HONG KONG, Sept. 15, 2025 /PRNewswire/ -- On 12 September, Home Control (1747.HK) announced a strategic expansion into the healthcare sector with plans to establish a wholly owned subsidiary in Hong K... -
CISION PR Newswire - Jointly discovered KAT6i molecule originating from...
Australian scientists who discovered how to "turn off" genes that make cancer cells grow are celebrating the next phase of development – with Pfizer's first in class KAT6 inhibitor PF-07248144 now mov... -
CISION PR Newswire - New Data, iCARE Study: Hailie® Smartinhaler® Power...
Highlights: Up to 235% increase in real-world adherence compared to published norms (20–40%), across ~850 chronic obstructive pulmonary disease (COPD) and asthma patients. >60% patients achieved a... -
CISION PR Newswire - Akeso Announces First Patient Dose in Global Regis...
HONG KONG, Sept. 15, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in its global, multicenter, randomized Phase II registrationa... -
CISION PR Newswire - EverBridge Group and Cosmotec Forge Landmark Partn...
SHANGHAI, Sept. 15, 2025 /PRNewswire/ -- EverBridge Group announced an Exclusive Commercialization Partnership with Cosmotec Inc. (a Wholly Owned Subsidiary of M3, Inc.; TSE: 2413) for the Japanese ma... -
CISION PR Newswire - Phrontline Biopharma Announces First Patient Dosed...
SHANGHAI and SUZHOU, China, Sept. 15, 2025 /PRNewswire/ -- Phrontline Biopharma, a clinical-stage biotechnology company advancing a new generation of Antibody-Drug Conjugates (ADCs), today announced t...
The information provided in this article was created by CISION PR Newswire, our news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of ELITE Beauty.